EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Bleeding symptoms in persons with rare bleeding disorders and a heterozygous genotype: data from the Rare Bleeding Disorders in the Netherlands study

Sterre P E Willems, Marjon H Cnossen, Nick van Es, Paul L den Exter, Ilmar C Kruis, Dominique P M S M Maas, Karina Meijer, Laurens Nieuwenhuizen, Sanna Rijpma, Joline L Saes, Annet Simons, Roger E G Schutgens und 4 weitere

Journal of Thrombosis and Haemostasis · 2025

DOI: 10.1016/j.jtha.2025.02.030 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Thrombosis and Haemostasis, 2025. Verfasst von Sterre P E Willems und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Radboud University Medical Center, Nijmegen, the Netherlands; Hemophilia Treatment Center, Nijmegen-Eindhoven-Maastricht, t…. Hauptthemen laut MEDLINE: Heterozygote, Postoperative Hemorrhage, Hemorrhage, Blood Coagulation Disorders. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Limited data exist on persons with rare bleeding disorders possessing a heterozygous genotype, as most studies focus on biallelic genotypes and more severe coagulation factor deficiencies. A growing body of evidence suggests that persons with a heterozygous genotype experience clinically relevant bleeding symptoms. OBJECTIVES: This study aimed to explore the incidence of bleeding symptoms and postoperative bleeding in persons with a heterozygous genotype. METHODS: This cross-sectional substudy of the Rare Bleeding Disorders in the Netherlands study (2017-2019) included persons with rare coagulation factor deficiencies and disorders of fibrinolysis with a heterozygous or biallelic genotype. Clinical data and laboratory samples were collected during a single study visit along with questionnaires. RESULTS: In total, 86 persons with a heterozygous genotype and 55 with a biallelic genotype were included. Median factor activity levels in persons with a heterozygous genotype approached 50% with considerable heterogeneity (range, 11%-93%). In 75%, persons with a heterozygous genotype reported bleeding severity of grade II or III. Female-specific bleeding was common. In total, 425 surgical procedures were performed. Persons with a heterozygous genotype were less likely to receive periprocedural treatment, and omission of periprocedural treatment was associated with postoperative bleeding in procedures with intermediate-high bleeding risk. Postoperative bleeding was comparable for persons with a heterozygous genotype (35%; 59/171) and a biallelic genotype (35%; 86/247; P = .926). CONCLUSION: In our population with rare bleeding disorders, the majority of persons possessing a heterozygous genotype exhibited spontaneous bleeding symptoms. Especially in intermediate-high risk procedures, a proactive approach to periprocedural hemostatic treatment in persons with a heterozygous genotype seems beneficial.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HeterozygotePostoperative HemorrhageHemorrhageBlood Coagulation DisordersRare DiseasesHumansNetherlandsFemaleMaleCross-Sectional StudiesMiddle AgedAdultAgedGenotypeIncidenceRisk FactorsPhenotypeYoung AdultGenetic Predisposition to Disease

Stichwörter der Autor:innen

blood coagulation disordersfibrinolysisgenotypehemostasisheterozygoteinherited

Autor:innen und Institutionen

  • Department of Hematology, Radboud University Medical Center, Nijmegen, the Netherlands; Hemophilia Treatment Center, Nijmegen-Eindhoven-Maastricht, the Netherlands.
  • Department of Pediatric Hematology and Oncology, Erasmus University Medical Center, Erasmus MC Sophia Children's Hospital, Rotterdam, the Netherlands.
  • Department of Vascular Medicine, Amsterdam UMC location University of Amsterdam, Amsterdam, the Netherlands; Amsterdam Cardiovascular Sciences, Pulmonary Hypertension and Thrombosis, Amsterdam, Netherlands.
  • Department of Medicine-Thrombosis and Hemostasis, Leiden University Medical Center, Leiden, the Netherlands.
  • Netherlands Hemophilia Society, Nijkerk, the Netherlands.
  • Department of Hematology, University Medical Center Groningen, Groningen, the Netherlands.

Zitieren

APA

Willems, S. P. E., Cnossen, M. H., van Es, N., den Exter, P. L., Kruis, I. C., Maas, D. P. M. S. M., Meijer, K., Nieuwenhuizen, L., Rijpma, S., Saes, J. L., Simons, A., Schutgens, R. E. G., Weiss, M., Blijlevens, N. M. A., van Heerde, W. L., & Schols, S. E. M. (2025). Bleeding symptoms in persons with rare bleeding disorders and a heterozygous genotype: data from the Rare Bleeding Disorders in the Netherlands study. Journal of Thrombosis and Haemostasis. https://doi.org/10.1016/j.jtha.2025.02.030

Vancouver

Willems SPE, Cnossen MH, van Es N, den Exter PL, Kruis IC, Maas DPMSM, et al. Bleeding symptoms in persons with rare bleeding disorders and a heterozygous genotype: data from the Rare Bleeding Disorders in the Netherlands study. Journal of Thrombosis and Haemostasis. 2025. doi:10.1016/j.jtha.2025.02.030

BibTeX
@article{Willems2025,
  author = {Willems, Sterre P E and Cnossen, Marjon H and van Es, Nick and den Exter, Paul L and Kruis, Ilmar C and Maas, Dominique P M S M and Meijer, Karina and Nieuwenhuizen, Laurens and Rijpma, Sanna and Saes, Joline L and Simons, Annet and Schutgens, Roger E G and Weiss, Marjan and Blijlevens, Nicole M A and van Heerde, Waander L and Schols, Saskia E M},
  title = {Bleeding symptoms in persons with rare bleeding disorders and a heterozygous genotype: data from the Rare Bleeding Disorders in the Netherlands study},
  journal = {Journal of Thrombosis and Haemostasis},
  year = {2025},
  doi = {10.1016/j.jtha.2025.02.030}
}
Kostenlos starten →